The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy
Open accessAbstract
Glucocorticoids (GCs) are widely used in the treatment of allergic skin conditions despite having numerous side effects. Here we use Cre/loxP-engineered tissue- and cell-specific and function-selective GC receptor (GR) mutant mice to identify responsive cell types and molecular mechanisms underlying the antiinflammatory activity of GCs in contact hypersensitivity (CHS). CHS was repressed by GCs only at the challenge phase, i.e., during reexposure to the hapten. Inactivation of the GR gene in keratinocytes or T cells of mutant mice did not attenuate the effects of GCs, but its ablation in macrophages and neutrophils abolished downregulation of the inflammatory response. Moreover, mice expressing a DNA binding-defective GR were also resistant to GC treatment. The persistent infiltration of macrophages and neutrophils in these mice is explained by an impaired repression of inflammatory cytokines and chemokines such as IL-1beta, monocyte chemoattractant protein-1, macrophage inflammatory protein-2, and IFN-gamma-inducible protein 10. In contrast TNF-alpha repression remained intact. Consequently, injection of recombinant proteins of these cytokines and chemokines partially reversed suppression of CHS by GCs. These studies provide evidence that in contact allergy, therapeutic action of corticosteroids is in macrophages and neutrophils and that dimerization GR is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypothesis is supported by prior work showing that repression of IL-1β, MIP-2, MCP-1, and IP-10 by GCs is hindered in macrophages isolated from GRdim mice (109, 110).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., Bock, R., Klein, R., & Schütz, G. (1999) · Nature Genetics · doi:10.1038/12703 · Cited by 1,841
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P. A., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,816
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21060 · Cited by 1,435
Deletion of a DNA Polymerase β Gene Segment in T Cells Using Cell Type-Specific Gene Targeting
Gu, H., Marth, J. D., Orban, P. C., Mossmann, H., & Rajewsky, K. (1994) · Science · doi:10.1126/science.8016642 · Cited by 1,397
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Self-citationLu, B., RUTLEDGE, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R. J., Gerard, C. J., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
T cell– and B cell–independent adaptive immunity mediated by natural killer cells
O’Leary, J. G., Goodarzi, M., Drayton, D. L., & von Andrian, U. H. (2006) · Nature Immunology · doi:10.1038/ni1332 · Cited by 920
Early molecular events in the induction phase of contact sensitivity.
Enk, A., & Katz, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1398 · Cited by 650
Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10
Lang, R., Patel, D. H., Morris, J. J., Rutschman, R., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2253 · Cited by 621
Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity.
Kaplan, D., Jenison, M., Saeland, S., Shlomchik, W. D., & Shlomchik, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.008 · Cited by 601
Macatonia, S. E., Knight, S. C., Edwards, A. J., Griffiths, S., & Fryer, P. R. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.6.1654 · Cited by 585
Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity
Grabbe, S., & Schwarz, T. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01186-9 · Cited by 513
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
Pasparakis, M., Courtois, G., Hafner, M., Schmidt‐Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israël, A., et al. (2002) · Nature · doi:10.1038/nature00820 · Cited by 471
Robbiani, D. F., Finch, R. A., Jäger, D., Müller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 455
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., & Schütz, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Corn, C., Soszynski, D., Grabiec, C., Trumbauer, M., Shaw, A. R., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90154-x · Cited by 404
Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G. A., Kunkel, S. L., Hültner, L., & Röcken, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1441 · Cited by 394
Piguet, P. F., Grau, G. E., Hauser, C. J., & VASSALLI, P. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.673 · Cited by 341
Constien, R., Forde, A., Liliensiek, B., Gröne, H., Nawroth, P. P., Hämmerling, G. J., & Arnold, B. (2001) · genesis · doi:10.1002/gene.1030 · Cited by 294
The glucocorticoid receptor is required for stress erythropoiesisPreprint
Bauer, A., Tronche, F., Wessely, O., Kellendonk, C., Reichardt, H. M., Steinlein, P., Schütz, G., & Beug, H. (1999) · Genes & Development · doi:10.1101/gad.13.22.2996 · Cited by 291
Wang, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27180 · Cited by 276
Interaction of SLP adaptors with the SH2 domain of Tec family kinases
Su, Y., Zhang, Y., Schweikert, J., Koretzky, G. A., Reth, M. G., & Wienands, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11 · Cited by 242
Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.
Shornick, L. P., Togni, P. D., Mariathasan, S., Goellner, J. J., Strauss‐Schoenberger, J., Karr, R. W., Ferguson, T. A., & Chaplin, D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1427 · Cited by 237
Keratinocytes in Inflammatory Skin Diseases
Albanesi, C., Scarponi, C., Giustizieri, M. L., & Girolomoni, G. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010054022033 · Cited by 232
Cross-talk between glucocorticoid receptor and AP-1
Herrlich, P. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204388 · Cited by 229
Wang, B., Fujisawa, H., Zhuang, L., Freed, I., Howell, B. G., Shahid, S., Shivji, G. M., Mak, T. W., & Sauder, D. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6783 · Cited by 228
Stratis, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27179 · Cited by 223
MOLECULAR MECHANISMS OF GLUCOCORTICOIDS IN THE CONTROL OF INFLAMMATION AND LYMPHOCYTE APOPTOSIS
Tuckermann, J. P., Kleiman, A., McPherson, K., & Reichardt, H. M. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590888983 · Cited by 203
Tuckermann, J. P., Reichardt, H. M., Arribas, R., Richter, K. H., Schütz, G., & Angel, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1365 · Cited by 196
Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344
Brodmerkel, C. M., Huber, R., Covington, M. B., Diamond, S., Hall, L. M., Collins, R. J., Leffet, L., Gallagher, K., Feldman, P., Collier, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5370 · Cited by 186
Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M., & Askenase, P. W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021562 · Cited by 167
Grabbe, S., Steinbrink, K., Steinert, M., Luger, T. A., & Schwarz, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4207 · Cited by 150
B Cell–dependent T Cell Responses
Tsuji, R. F., Szczepanik, M., Kawiková, I., Paliwal, V., Campos, R. A., Itakura, A., Akahira-Azuma, M., Baumgarth, N., Herzenberg, L. A., & Askenase, P. W. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020649 · Cited by 122
Tsuji, R. F., Kawiková, I., Ramabhadran, R., Akahira-Azuma, M., Taub, D. D., Hugli, T. E., Gerard, C. J., & Askenase, P. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1588 · Cited by 114
McHale, J. F., Harari, O., Marshall, D., & Haskard, D. O. (1999) · PubMed · Cited by 106
Cultured Epidermal Langerhans Cells Activate Effector T Cells for Contact Sensitivity
Hauser, C. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12555587 · Cited by 105
McHale, J. F., Harari, O., Marshall, D., & Haskard, D. O. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1648 · Cited by 99
A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.
Bullard, D. C., Scharffetter‐Kochanek, K., McArthur, M. J., Chosay, J. G., McBride, M. E., Montgomery, C. A., & Beaudet, A. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2116 · Cited by 87
Baumann, S., Dostert, A., Novac, N., Bauer, A., Schmid, W., Fas, S. C., Krueger, A., Heinzel, T., Kirchhoff, S., Schütz, G., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4390 · Cited by 83
New insights into atopic dermatitis
Leung, D. Y. M., Boguniewicz, M., Howell, M. D., Nomura, I., & Hamid, Q. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421060 · Cited by 83
Askenase, P. W. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01619.x · Cited by 71
Targeted Somatic Mutagenesis in Mouse Epidermis
Indra, A. K., Li, M., Brocard, J., Warot, X. M., Bornert, J., Gérard, C., Messaddeq, N., Chambon, P., & METZGER, D. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053275 · Cited by 65
Hwang, J. M., Yamanouchi, J., Santamaría, P., & Kubes, P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032016 · Cited by 63
Tumpey, T. M., Fenton, R. R., Molesworth-Kenyon, S. J., Oakes, J. E., & Lausch, R. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8050-8057.2002 · Cited by 61
Cytokine knockouts in contact hypersensitivity research
Wang, B., Esche, C., Mamelak, A. J., Freed, I., Watanabe, H., & Sauder, D. N. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00050-9 · Cited by 54
Campos, R. A., Szczepanik, M., Itakura, A., Lisbonne, M., Dey, N., Leite‐de‐Moraes, M., & Askenase, P. W. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02330.x · Cited by 41
Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals
Cumberbatch, M., Dearman, R. J., & Kimber, I. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00037-5 · Cited by 40
Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity
Mitsui, G. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00017-8 · Cited by 36
The role of CXCR2 activity in the contact hypersensitivity response in mice.
Cattani, F., Gallese, A., Mosca, M., Buanne, P., Biordi, L. A., Francavilla, S., Coletti, G., Pellegrini, L., Melillo, G., & Bertini, R. (2006) · PubMed · Cited by 27
Research works printed but not linked: 2
- Indra, 2000, Horm. Res., 54, 296
- Cattani, 2006, Eur. Cytokine Netw., 17, 42
Cited by
Sorted by citations
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“, 2007), and although TNF remainedglucocorticoid-suppressible inGRdimmacrophages, MCP-1 and MIP-2 were not repressed (Tuckermann et al., 2007).”
InfluentialImmune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
“& Cidlowski, 2015; Tuckermann et al., 2007).”
Silverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 775
One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Cruz‐Topete, D., & Cidlowski, J. A. (2014) · NeuroImmunoModulation · doi:10.1159/000362724 · Cited by 481
Metadata
- Authors
- Tuckermann, J. P., Kleiman, A., Moriggl, R., Spanbroek, R., Neumann, A., Illing, A., Clausen, B. E., Stride, B., Förster, I., Habenicht, A. J. R., Reichardt, H. M., Tronche, F., Schmid, W., & Schütz, G.
- Affiliations
- German Cancer Research Center (DE)
- Ludwig Boltzmann Institute for Cancer Research (AT)
- Friedrich Schiller University Jena (DE)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Amsterdam UMC Location University of Amsterdam (NL)
- Heinrich Heine University Düsseldorf (DE)
- University of Göttingen (DE)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Tuckermann, Jan P.
- Schütz, Günther
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-05-01
- Volume
- 117
- Issue
- 5
- Pages
- 1381-1390
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1849982
- OpenAlex
- W2060990402
- Cited by
- 252
- References
- 54
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 18 · 2017: 16 · 2016: 15 · 2015: 11 · 2014: 14 · 2013: 11 · 2012: 20
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Deutsches Krebsforschungszentrum (69120, D-69120)
- Landsteiner Foundation for Blood Transfusion Research
- Deutsche Forschungsgemeinschaft (SFB405, SFB 636, SFB 488)
- Bundesministerium für Bildung und Forschung (01GS0477, 01GZ0310, KGCV1, 01GS0416)
- Austrian Science Fund (SFB‐F28)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (917.76.365)
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, contact hypersensitivity, contact allergy, macrophages, neutrophils, glucocorticoid receptor, anti-inflammatory mechanism, chemokines, inflammatory cytokines, keratinocytes, T cells, skin inflammation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cells, Cultured, Dexamethasone, Immunosuppressive Agents, Macrophages, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Neutrophils, Receptors, Glucocorticoid, Drug Delivery Systems, Dermatitis, Allergic Contact, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review